Skip to content

Kadant KAI Shares Reserved for Future Issuance Under Stock Plans

Shares Reserved for Future Issuance Under Stock Plans at other companies

Flowserve logo
FlowserveFLS
Xylem logo
XylemXYL

Other financials

Income statement

See full
Revenue$281.5M+17.7%
Gross profit$126.7M+14.8%
Operating income$40.1M+12.7%
Net income$25.5M+6.0%
EPS (diluted)$2.16+5.9%

Balance sheet

See full
Cash & equivalents$119.8M+27.7%
Total debt$368.6M+30.6%
Total equity$995.6M+13.7%
Total assets$1.7B+19.5%

Cash flow

See full
Operating cash flow$21.9M-4.0%
CapEx$3.3M-15.1%
Free cash flow$18.7M-1.8%

Valuation

See full
Market cap$3.55B-6.9%

Profitability

See full
Gross margin45%+0.4pp
Operating margin14.8%-1.5pp
Net margin9.4%-1.2pp
FCF margin14.1%+1.0pp

Returns & leverage

See full
Return on equity11.1%-2.3pp
Debt / equity0.4×0.0×
Current ratio2.5×0.0×

Where this comes from

Reported directly by Kadant in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: Kadant’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kadant's shares reserved for future issuance under stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kadant's shares reserved for future issuance under stock plans?
Kadant (KAI) reported shares reserved for future issuance under stock plans of 366.3K in Q4 2025.
How has Kadant's shares reserved for future issuance under stock plans changed year-over-year?
Kadant's shares reserved for future issuance under stock plans decreased by 10.5% year-over-year, from 409.2K to 366.3K.
What is the long-term trend for Kadant's shares reserved for future issuance under stock plans?
Over 5 years (2020 to 2025), Kadant's shares reserved for future issuance under stock plans has grown at a -9.8% compound annual growth rate (CAGR), from 613K to 366.3K.
What does shares reserved for future issuance under stock plans mean?
This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.